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were furthermore compared using correlation and regres-
sion analyses.  Results: Three factors were revealed for the 
CDSS and HAMD-17 factor component analysis. A very simi-
lar item loading was found for the CDSS at admission and 
discharge, whereas results of the loadings of the HAMD-17 
items were less stable. The first two factors of the CDSS re-
vealed correlations with positive, negative and general psy-
chopathology. In contrast, multiple significant correlations 
were found for the HAMD-17 factors and the PANSS sub-
scores. Multiple regression analyses demonstrated that the 
HAMD-17 accounted more for the positive and negative 
symptom domains than the CDSS.  Conclusions: The present 
results suggest that compared to the HAMD-17, the CDSS is 
a more specific instrument to measure depressive symp-
toms in schizophrenia and schizophrenia spectrum disorder, 
especially in acutely ill patients. 
 Copyright © 2012 S. Karger AG, Basel 
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 Abstract 
 Background: The aim of this study was to compare two
measures of depression in patients with schizophrenia and 
schizophrenia spectrum disorder, including patients with 
delusional and schizoaffective disorder, to conclude implica-
tions for their application.  Sampling and Methods: A total 
of 278 patients were assessed using the Calgary Depression 
Scale for Schizophrenia (CDSS) and the Hamilton Depression 
Rating Scale (HAMD-17). The Positive and Negative Syn-
drome Scale (PANSS) was also applied. At admission and dis-
charge, a principal component analysis was performed with 
each depression scale. The two depression rating scales 
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 Introduction 
 Depressive symptoms are thought to represent an im-
portant symptom domain in schizophrenia patients  [1] , 
with prevalence estimates ranging to as high as 80%  [2] . 
Depressive symptoms have been associated with impair-
ments in social and vocational functioning, quality of life 
and an increased risk of relapse  [3, 4] . They were found to 
increase mortality rates in patients with schizophrenia by 
contributing to the alarmingly high rates of suicide  [5] . 
Therefore, measuring symptoms of depression has be-
come of increasing interest and importance in the past 
years in schizophrenia research  [6] .
 However, a difficulty in assessing depressive symp-
toms in schizophrenia has been noted, mainly due to a 
lack of specifically developed rating scales to examine
depressive symptoms in this patient population  [7] . The 
most commonly used rating scale has been the Hamilton 
Depression Rating Scale (HAMD), developed during the 
late 1950s as a standardized scale for the measurement of 
the severity of depressive symptoms in inpatients with 
depressive disorders  [8] . However, the HAMD was found 
to be significantly influenced by negative and extrapyra-
midal symptoms in schizophrenia, placing its use in this 
patient population in doubt  [9] . The concern of using 
scales in populations for which they were not designed 
was already critically discussed by Hamilton himself. 
Consequently, to overcome these limitations, the Calgary 
Depression Scale for Schizophrenia (CDSS) has been de-
veloped to specifically assess depression in patients with 
schizophrenia  [10] . The superiority of the CDSS origi-
nates from its psychometric properties  [11, 12] , and fur-
thermore, its discriminant and convergent validity have 
been reported in many studies  [13] .
 Addington et al.  [14] were among the first to examine 
depressive symptoms in acutely hospitalized schizophre-
nia patients; they showed that the HAMD accounted for 
more of the variance in positive and negative symptoms 
than the CDSS, suggesting that the CDSS is a more spe-
cific measure of depression than the HAMD. In a similar 
analysis by Müller et al.  [15] in 119 inpatients with acute 
schizophrenia, again significant advantages were found 
to emerge with the CDSS when compared to the HAMD. 
Collins et al.  [16] were able to confirm these results in 
schizophrenia outpatients with a mean duration of illness 
of 14.95 years and comparing the CDSS not only to the 
HAMD but also to the depression subscale of the Positive 
and Negative Syndrome Scale (PANSS). However, previ-
ous research comparing the CDSS and the HAMD bears 
several methodological pitfalls such as very small sample 
sizes with fewer than 100 patients  [9, 14] and mainly per-
forming correlation analyses providing only limited in-
formation on the scales’ individual properties.
 Therefore, the aim of this study was to reevaluate these 
results within a larger and ‘real-world’ patient sample in 
order to provide an up-to-date recommendation regard-
ing which rating scale is best to apply.
 Methods 
 Subjects 
 Data were collected in a multicenter follow-up programme 
(German Research Network on Schizophrenia)  [17] at eleven psy-
chiatric university hospitals and three psychiatric district hospi-
tals in the region surrounding Munich. All patients admitted to 
one of the above-mentioned hospitals between January 2001 and 
December 2004 with the diagnosis of schizophrenia, schizo-
phreniform disorder, delusional disorder or schizoaffective disor-
der according to DSM-IV criteria were selected for inclusion. Pa-
tient selection was performed using randomization software. 
Subjects were aged between 18 and 65 years. The exclusion criteria 
of this study were defined as a head injury, a history of major 
medical illness or alcohol or drug dependency. Informed written 
consent had to be provided to participate in the study. The study 
protocol was approved by the local ethics committees  [18] .
 Assessments 
 DSM-IV diagnoses were established by clinical researchers on 
the basis of the German version of the Structured Clinical Inter-
view for DSM-IV  [19] . Sociodemographic and course-related 
variables such as age at onset, age at first hospitalization or epi-
sodes of illness were collected using a standardized documenta-
tion system  [20] during interviews with patients, relatives and 
care providers.
 Depressive symptoms were examined by applying the CDSS 
 [21] . The CDSS is a 9-item questionnaire (depression, hopeless-
ness, self-depreciation, guilty ideas of reference, pathological 
guilt, morning depression, early wakening, suicide, observed de-
pression) with a global score range of 0–27 points. The 17-item 
version of the HAMD (HAMD-17)  [8] was also applied. The pa-
tients’ positive, negative and general psychopathology was as-
sessed using the PANSS  [22] . All raters had been trained to use the 
applied scales. A high inter-rater reliability was achieved (Intra-
Class-Correlation  1 0.8).
 Statistical Analysis 
 To identify patients suffering from depressive symptoms, 
widely accepted cut-off scores of the CDSS and the HAMD-17 
were applied. A cut-off score of  1 6 points has been proposed for 
the CDSS  [21] and a cut-off score of  6 16 points for the HAMD-17 
 [23] to separate depressed and non-depressed patients.
 Factor analysis using the principal component method was 
calculated in order to identify latent structures underlying the 
data. This procedure transforms a number of possibly correlated 
variables into a smaller number of variables called principal com-
ponents. The first principal component accounts for as much of 
the data’s variability as possible, with every succeeding compo-
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nent accounting for as much of the remaining variability as pos-
sible. Given the naturalistic and descriptive approach of this 
study, an explorative factor analysis was performed descriptively 
examining the two depression scales.
 Parallel plots were used in order to determine a reasonable 
number of factors. This technique compares the eigenvalues of the 
original data with the eigenvalues of its random permutations. 
This method was shown to be superior to the simple eigenvalue-
greater-than-one rule  [24] . Principal component analysis was per-
formed using a correlation matrix; the oblique rotation was based 
on the assumption that significant correlations exist between the 
instrument factors (promax rotation). Principal component anal-
ysis was applied to both the CDSS and the HAMD-17 at admission 
and at discharge. To attain a clear arrangement of the results, only 
loadings with an absolute value greater than 0.4 are presented; by 
this means, only loadings of items which contribute substantially 
to a factor are shown. The signs of the loadings in this context are 
of secondary interest and only due to the rotation technique; if all 
loadings of a factor show the same sign, the involved items con-
tribute in the same direction to this factor.
 Accordingly, Pearson’s correlation coefficient was used to ex-
amine the correlation between the factors of the CDSS, the factors 
of the HAMD and the PANSS subscores. The value of significance 
was calculated based on a t test for Pearson’s correlation coeffi-
cient. Additionally, multiple regression analyses were performed 
with CDSS and HAMD factors as predictor variables and the 
PANSS subscores as dependent variables.
 All statistical analyses were performed using the statistical 
program R 2.10.1  [25] .
 Results 
 Patients 
 In the entire multicenter study, 474 patients were en-
rolled. Forty-six patients had to drop out for different 
reasons (e.g. retrospective violation of inclusion criteria, 
withdrawal of informed consent). Another 150 patients 
were excluded from this analysis, 28 patients because 
they were discharged from hospital within 7 days after 
admission and thus no follow-up rating was available 
and 122 patients due to missing or inconsistent CDSS 
values. Therefore, the sample available for analysis com-
prised 278 subjects (163 males, 115 females). The mean 
age was 34.77 years ( 8 11.07), and the mean duration of 
illness 7.68 years ( 8 9.14). The mean number of hospital-
izations was 3.94 ( 8 5.68). The mean duration of the cur-
rent hospitalization was 68.78 days ( 8 49.65), and the 
mean age at first treatment, mirroring the patient’s age 
at onset, was 27.03 years ( 8 8.82). Forty-six percent of pa-
tients were employed and 54% were jobless. At admis-
sion, 26% of the patients suffered from suicidality. None 
of the patients had the diagnosis of a comorbid major de-
pressive episode.
 Patients were treated under naturalistic conditions; 
51% of the patients received a first-generation antipsy-
chotic, 79% of patients were given second-generation an-
tipsychotic treatment and 41% of the patients were treated 
with first- as well as second-generation antipsychotics. 
Tranquilizers were administered to 66% of patients and 
mood stabilizers to 12%. Thirty-three percent of the pa-
tients were also treated with antidepressants.
 Psychopathological Ratings 
 At admission, the mean CDSS total score was 6.41 
( 8 4.71) and the mean HAMD-17 total score was 13.56 
( 8 6.72). The mean PANSS positive subscore was 18.99 
( 8 6.49); the mean PANSS negative subscore was 18.41 
( 8 7.45); the mean PANSS general psychopathology sub-
score was 36.62 ( 8 10.08), and the mean PANSS total score 
was 74.01 ( 8 19.46). Applying accepted cut-offs, a similar 
number of patients were found to be depressed using the 
CDSS and the HAMD-17 at admission (CDSS: 90 patients; 
HAMD-17: 86 patients; 54 patients concurrently scored 
 1 6 on the CDSS and  6 16 on the HAMD-17).
 At discharge, the mean CDSS total score was 2.63 
( 8 3.55) and the mean HAMD-17 total score was 7.86 
( 8 6.2). The mean PANSS positive subscore was 10.81 
( 8 3.96); the mean PANSS negative subscore was 14.84 
( 8 6.28); the mean PANSS general psychopathology sub-
score was 26.35 ( 8 7.82), and the mean PANSS total score 
was 52 points ( 8 15.43). Again, a very similar number of 
patients suffered from depressive symptoms at discharge 
when applying the CDSS and the HAMD-17 (CDSS: 27 
patients; HAMD-17: 26 patients; 11 patients concurrently 
scored  1 6 on the CDSS and  6 16 on the HAMD-17).
 Scatter plots analysed at admission and discharge 
showed that the CDSS and HAMD total scores moved in 
the same direction, suggesting a linear correlation be-
tween the scales’ total scores ( fig. 1 ).
 Factor Analysis of the CDSS 
 Based on parallel plots, 3 factors were revealed for the 
CDSS factor component analysis.
 At Admission  
 The loadings of the principal component factor analy-
sis of the CDSS at admission are shown in  table 1 . The 
items ‘depressed mood’, ‘hopelessness’ and ‘self-depreci-
ation’ as well as ‘suicide’ and ‘observed depression’ were 
found to load on factor 1, which accounted for 30% of the 
variance. The item ‘self-depreciation’ loaded on factors 1 
and 2. Factor 2 was based on items referring to guilt, ac-
counting for 19% of the variance, and factor 3 referred to 
 A Psychometric Comparison of Two 
Depression Rating Scales 
Psychopathology 2012;45:276–285 279
the items ‘morning depression’ and ‘early wakening’, ac-
counting for 16% of the variance. The overall Cronbach’s 
  was 0.78, suggesting good internal consistency.
 At Discharge 
 A very similar factor structure was found for the CDSS 
at discharge ( table 2 ). The item ‘self-depreciation’ loaded 
solely on factor 2 at discharge; all other items were related 
to the same factors as at admission. The overall Cron-
bach’s   was 0.83.
 Factor Analysis of the HAMD-17 
 Based on parallel plots, 3 factors were revealed for the 
HAMD-17 factor component analysis.
 At Admission 
 Results of the factor analysis of the HAMD-17 are 
shown in  table  3 . Items on somatic experiences, hypo-
chondriasis, interest in work and retardation loaded on 
factor 1, accounting for 14% of the variance. Factor 2 re-
ferred to anxiety and insomnia, also accounting for 14% 
of the variance. The third factor loaded the depression 
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 Fig. 1. Scatter plots of CDSS and HAMD-17 total scores at admission and discharge. 
Table 1. F actor analysis of the CDSS at admission
Factor 1 Factor 2 Factor 3
CDSS items
1. Depressed mood –0.83
2. Hopelessness –0.75
3. Self-depreciation –0.51 0.57
4. Guilty ideas of reference 0.84
5. Pathological guilt 0.76
6. Morning depression –0.71
7. Early wakening –0.86
8. Suicide –0.58
9. Observed depression –0.84
Sum of square loadings 2.70 1.72 1.45
Proportional variance 0.30 0.19 0.16
Cronbach’s  (overall variance: 0.78) 0.79 0.66 0.53
Table 2. F actor analysis of the CDSS at discharge
Factor 1 Factor 2 Factor 3
CDSS items
1. Depressed mood –0.82
2. Hopelessness –0.69
3. Self-depreciation –0.64
4. Guilty ideas of reference –0.88
5. Pathological guilt –0.83
6. Morning depression 0.76
7. Early wakening 0.86
8. Suicide –0.68
9. Observed depression –0.83
Sum of square loadings 2.54 2.18 1.57
Proportional variance 0.28 0.24 0.17
Cronbach’s  (overall variance: 0.83) 0.82 0.74 0.60
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item as well as items on guilt and suicide, accounting for 
only 12% of the variance. The overall Cronbach’s   was 
0.72.
 At Discharge  
 The results of the factor analysis of the HAMD-17 at 
discharge differed considerably from the results at ad-
mission ( table  4 ). Compared to admission, factor 1 in-
cluded the item ‘depression’ at discharge, accounting for 
16% of the variance. The items ‘guilt’ and ‘suicide’ loaded 
on factor 2 at discharge, whereas items on anxiety loaded 
on factor 3. The overall Cronbach’s   was 0.79.
 Pearson’s Correlation Coefficients of the CDSS and 
HAMD-17 Total Scores and of the CDSS Factors, 
HAMD-17 Factors and PANSS Subscores 
 The CDSS total score and the HAMD-17 total score 
were significantly correlated at admission (p  ! 0.001; cor-
relation coefficient 0.59) and at discharge (p  ! 0.001; cor-
relation coefficient 0.59). The CDSS factors were found to 
be less often significantly correlated to the PANSS sub-
scores than the HAMD-17 factors at admission and dis-
charge ( tables 5, 6 ). This applied especially to the third 
CDSS factor, which was not significantly correlated to 
any of the PANSS subscores at admission or discharge.
 Multiple Regression Analysis of the CDSS Factors, 
HAMD-17 Factors and PANSS Subscores 
 At admission, the results of the multiple regression 
analysis indicated that the CDSS factors explained less of 
the PANSS subscores than did the HAMD-17 factors ( ta-
ble 7 ). However, at discharge, a similar level of explained 
variance was found between the CDSS and HAMD-17 
factors and the PANSS subscores ( table 8 ).
 Association between CDSS, HAMD-17, CDSS Factors 
and HAMD-17 Factors and Gender and Patients’ 
Outcome 
 At admission, female patients were found to score sig-
nificantly higher (p  ! 0.0001) on the CDSS mean score as 
well as on CDSS factor 1. On discharge, men scored sig-
nificantly higher on CDSS factor 3 (p  ! 0.0001) with the 
items ‘morning depression’ and ‘early wakening’.
 Comparing the mean CDSS and HAMD-17 values as 
well as the CDSS and HAMD-17 factors in terms of an 
association with the patients’ outcome, no significant dif-
Table 3. F actor analysis of the HAMD-17 at admission
Factor 1 Factor 2 Factor 3
HAMD items
1. Depression 0.57
2. Guilt 0.50
3. Suicide 0.69
4. Insomnia – E –0.68
5. Insomnia – M –0.78
6. Insomnia – L –0.68
7. Work/interest –0.70
8. Retardation –0.55
9. Agitation –0.45
10. Anxiety – psychic –0.42
11. Anxiety – somatic –0.45 –0.43
12. Somatic – GI 0.48
13. Somatic – general –0.66
14. Libido
15. Hypochondriasis –0.43
16. Loss of weight 0.42
17. Loss of insight
Sum of square loadings 2.26 2.33 1.97
Proportional variance 0.14 0.14 0.12
Cronbach’s  (overall variance: 0.72) 0.59 0.57 0.57
E = Early; M = middle; L = late; GI = gastrointestinal.
Table 4. F actor analysis of the HAMD-17 at discharge
Factor 1 Factor 2 Factor 3
HAMD items
1. Depression –0.73
2. Guilt 0.40
3. Suicide 0.42
4. Insomnia – E 0.66
5. Insomnia – M 0.73
6. Insomnia – L 0.69
7. Work/interest –0.61
8. Retardation –0.70
9. Agitation 0.65
10. Anxiety – psychic 0.56
11. Anxiety – somatic 0.49
12. Somatic – GI –0.51
13. Somatic – general –0.57
14. Libido
15. Hypochondriasis 0.60
16. Loss of weight
17. Loss of insight 0.61
Sum of square loadings 2.68 2.20 2.21
Proportional variance 0.16 0.13 0.13
Cronbach’s  (overall variance: 0.79) 0.69 0.62 0.60
E = Early; M = middle; L = late; GI = gastrointestinal.
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Table 5. P earson correlation analysis of the CDSS factors, HAMD-17 factors and PANSS subscores at admission
PANSS positive PANSS negative PANSS general 
CDSS total score –0.02 (–0.14 to 0.1) 0.32*** (0.22–0.43) 0.40*** (0.22–0.43)
CDSS factor 1 0.04 (–0.08 to 0.16) –0.35*** (–0.45 to –0.24) –0.39*** (–0.42 to –0.2)
CDSS factor 2 0.18** (0.06–0.29) –0.06 (–0.17 to 0.06) 0.16** (0.08–0.31)
CDSS factor 3 0.04 (–0.08 to 0.16) 0.11 (–0.01 to 0.23) –0.04 (–0.18 to 0.05)
HAMD-17 total score 0.21*** (0.09–0.32) 0.32*** (0.21–0.43) 0.46*** (0.32–0.52)
HAMD-17 factor 1 –0.17** (–0.28 to –0.05) –0.31*** (–0.41 to –0.2) –0.44*** (–0.49 to –0.29)
HAMD-17 factor 2 –0.07* (0.18–0.41) 0.37*** (0.27–0.47) 0.16** (0.01–0.24)
HAMD-17 factor 3 –0.27*** (0.37 to –0.15) –0.14* (–0.25 to –0.02) –0.18** (–0.33 to –0.11)
Figures in parentheses represent confidence intervals * p < 0.05; * p < 0.01; * p < 0.001. 
Table 6. P earson correlation analysis of the CDSS factors, HAMD-17 factors and PANSS subscores at discharge
PANSS positive PANSS negative PANSS general 
CDSS total score 0.34** (0.23–0.44) 0.34*** (0.23–0.44) 0.52*** (0.43–0.6)
CDSS factor 1 –0.33 (–0.43 to 0.22) –0.35*** (–0.45 to –0.24) –0.52*** (–0.6 to –0.43)
CDSS factor 2 0.01 (–0.21 to –0.12) 0.24 (–0.13 to 0.35) 0.06 (–0.06 to 0.17)
CDSS factor 3 –0.02 (–0.13 to 0.1) 0.09 (–0.03 to 0.2) 0.04 (–0.08 to 0.16)
HAMD-17 total score 0.32*** (0.21–0.42) 0.32*** (0.21–0.42) 0.41*** (0.31–0.5)
HAMD-17 factor 1 –0.29*** (–0.4 to –0.18) –0.3*** (–0.4 to –0.19) –0.39*** (–0.49 to –0.29)
HAMD-17 factor 2 –0.13* (–0.25 to –0.01) –0.1 (–0.22 to 0.02) –0.03 (–0.14 to 0.09)
HAMD-17 factor 3 0.17 (–0.06 to 0.28) –0.25 (–0.36 to 0.14) –0.02 (–0.13 to 0.1)
Figures in parentheses represent confidence intervals. * p < 0.05; * p  < 0.01; * p < 0.001.
Table 7. M ultiple regression analysis of the CDSS factors, HAMD-
17 factors and PANSS subscores at admission
Predictor 
variable
Dependent
variable
Multiple 
r
r2 p 
value
CDSS
factors
PANSS positive
PANSS negative
PANSS general
0.04
0.13
0.18
0.19 (0.08–0.3)
0.37 (0.27–0.46)
0.42 (0.27–0.48)
0.02
0.00
0.00
HAMD-17 
factors
PANSS positive
PANSS negative
PANSS general
0.10
0.23
0.24
0.32 (0.21–0.43)
0.48 (0.38–0.57)
0.49 (0.36–0.56)
0.00
0.00
0.00
Figures in parentheses represent confidence intervals.
Table 8. M ultiple regression analysis of the CDSS factors, HAMD-
17 factors and PANSS subscores at discharge
Predictor 
variable
Dependent
variable
Multiple
r
r2 p 
value
CDSS
factors
PANSS positive
PANSS negative
PANSS general
0.11
0.16
0.35
0.33 (0.19–0.48)
0.40 (0.3–0.5)
0.52 (0.41–0.63)
0.00
0.00
0.00
HAMD-17 
factors
PANSS positive
PANSS negative
PANSS general
0.13
0.14
0.20
0.36 (0.25–0.47)
0.37 (0.27–0.48)
0.40 (0.29–0.51)
0.00
0.00
0.00
Figures in parentheses represent confidence intervals.
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ferences were found at admission. However, at discharge, 
a significant association was found comparing early re-
sponders/non-early responders in terms of the mean 
CDSS (p = 0.0088) and the mean HAMD-17 (p = 0.0397) 
and CDSS factor 1 (p = 0.0101). Comparing responders/
non-responders and remitters/non-remitters, signifi-
cantly lower scores were found for the mean CDSS (p  ! 
0.0001), the mean HAMD-17 (p  ! 0.0001), CDSS factor 1 
(p  ! 0.0001) and HAMD-17 factor 1 (p  ! 0.0001). Re-
sponders also scored significantly lower on HAMD-17 
factor 2 (p = 0.0357).
 Discussion 
 Analysing the CDSS 
 Factor Analysis 
 Our results of the factor analyses of the CDSS showed 
a stable underlying 3-factorial structure at both assess-
ment time points with an almost identical loading of the 
CDSS items on factors 1–3. At admission, the cumulative 
variance of the factor analysis was 65%, and at discharge, 
it was 70%. This indicates that the revealed factors ex-
plain the distribution of the CDSS items for the most part. 
Our 3 identified factors (‘general depression and hope-
lessness factor’, ‘guilt factor’ and ‘morning depression 
and early wakening factor’) have already been described 
in the literature, which confirms the scale’s satisfying 
psychometric properties  [14, 26] .
 However, other authors have referred to the second 
factor as the ‘cognitive factor’, based more on the percep-
tion and cognition of guilt than on the domain of guilt 
itself  [14] . The third factor, although only comprehending 
one item, or as in our own results two items, is thought to 
be of clinical relevance in representing melancholia. It 
was furthermore found to be an important specifier for a 
major depressive episode  [14] .
 Interestingly, the loadings of the 3 factors were stable 
from admission to discharge, indicating that the factorial 
structure is stable independent of significant improve-
ment in the clinical status of the examined patients 
throughout the course of the study. The same factorial 
stability was found by Addington et al.  [14] , who exam-
ined acutely relapsed schizophrenia patients with a 
3-month follow-up assessment time point implying a 
time point of relative remission similar to the present 
study. These properties of the scale with high internal 
consistency are furthermore underlined by results of the 
psychometric properties of the scale in a healthy control 
group reporting reference values for clinical use  [27] .
 Correlation and Regression Analyses of the Revealed 
CDSS Factors 
 In contrast to other trials examining the CDSS in 
schizophrenia patients, we found the CDSS total score as 
well as CDSS factor 1 to be significantly correlated to the 
PANSS negative subscore  [16, 28, 29] . The negligible cor-
relation between the CDSS and negative symptoms re-
ported by other authors has always been thought to be a 
valuable and unique characteristic of the CDSS compared 
to other rating scales  [14, 30] . However, our results find-
ing a correlation between negative symptoms and the 
CDSS might be due to differences in the sample selection 
and methodological approaches (e.g. rater behaviour) 
compared to other studies. For example, in the present 
study the same raters performed the CDSS and PANSS 
ratings, which might at least partially contribute to the 
present findings. Also, suicidal patients and patients with 
severe depression, indicated by a greater standard devia-
tion than reported in the comparative literature, were in-
cluded. Still, this result somewhat challenges current re-
search opinions stating that depressive symptoms are an 
integral part of schizophrenia psychopathology and in-
dependent of, for example, negative symptoms  [2] . How-
ever, given the fact that both the depressive and negative 
psychopathological domains cover symptoms like social 
withdrawal or lack of spontaneity, an overlap and correla-
tion between these domains is evident, thereby affecting 
the assessment of depressive symptoms  [31] . However, if 
and to what extent depressive and negative symptoms in 
schizophrenia are divergent remains unclear and should 
be the focus of future research, resulting in a better un-
derstanding of schizophrenia psychopathology.
 In line with current literature reports, we found a 
strong and significant correlation of CDSS factor 2 with 
positive symptoms  [26] . It is believed that guilty ideas of 
reference are similar to the symptoms of delusions of guilt 
 [14] , contributing to the significant correlation between 
these domains.
 Similar results were found at discharge, whereby fac-
tor 1 correlated significantly to all PANSS subscores and 
the CDSS factor on guilt was only found to significantly 
correlate to the PANSS positive subscore. Regarding the 
results of the multiple regression analysis, the CDSS was 
found to account for all three PANSS subscores, with the 
lowest association between the CDSS and positive symp-
toms, followed by negative symptoms and general psy-
chopathology. Again, our findings of an association be-
tween the CDSS and negative symptoms are conflicting, 
as discussed above.
 A Psychometric Comparison of Two 
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 Analysing the HAMD-17 
 Factor Analysis 
 The factor analysis of the HAMD-17 at admission and 
discharge varied considerably, explaining 40% of the cu-
mulative variance at admission and 42% of the cumu-
lative variance at discharge. Comparative literature in 
schizophrenia patients is very limited, and to our knowl-
edge there are only two other trials that have examined 
the HAMD factorial structure in schizophrenia  [9, 14] . 
Both comparative studies applied a different statistical 
method to identify the number of factors for the principal 
component analysis, using 6 and 7 factors, respectively, 
and thus limiting comparability to the present results  [9, 
14] . However, both studies examined two different time 
points and also found the HAMD to be unstable. Gold-
man et al.  [9] identified only 6 of 17 items loading on the 
same factors at both assessment time points. Also, Ad-
dington et al.  [14] reported a massive change in factor 
loading occurring between the examined time points.
 At admission in our study, the highest loading on the 
first factor was found for the item ‘work interest’, followed 
by ‘general somatic’, ‘anxiety somatic’, ‘retardation’ and 
‘hypochondriasis’. This loading of items on the first factor 
is at least partially different from data deriving from fac-
tor analyses of the HAMD performed in patients with de-
pression  [32] . Early on, Hamilton  [33] found the first fac-
tor to measure general depression incorporating items 
like ‘depressed mood’ or ‘suicide’. In our study, we did 
find a so-called ‘general depression factor’, namely the 
third factor, loading ‘typical’ depression items. The main 
explanation for these contradictory results probably lies 
in the different patient samples examined. It is not sur-
prising that the dimension of depression in schizophrenia 
patients differs from what we observe in depressed pa-
tients  [30] . Besides, in acutely ill schizophrenia patients, 
symptoms like anxiety or hypochondriac delusions might 
be more prominent than depressive symptoms, which 
might also explain the observed items’ loading.
 However, interestingly, even in factor analyses of the 
HAMD in depression, inconsistent results have been re-
ported. In a review of 15 studies with 17 samples of de-
pressed patients, Bagby et al.  [34] found several differ-
ences regarding the item loading on specific factors and 
concluded that the HAMD is clearly not unidimensional.
 At discharge, we were able to confirm the HAMD fac-
tors of anxiety and insomnia which have been described 
in patients with depression  [35] , whereas at admission, 
both symptom domains loaded on the same factor. Based 
on the better differentiated loading of items at discharge 
with greater similarity to the factors found in depression, 
our results suggest that measuring depression using the 
HAMD might be more appropriate in stable schizophre-
nia patients rather than acutely ill ones.
 Correlation and Regression Analyses of the Revealed 
HAMD Factors 
 At admission, all HAMD factors as well as the HAMD 
total score were significantly correlated to the PANSS 
subscores, which has been consistently reported in pa-
tients suffering from schizophrenia  [16, 28] . Comparison 
of our results between admission and discharge is limited 
due to different items loading on the 3 HAMD factors. 
However, considerably less significant correlations were 
observed between the HAMD factors and the PANSS 
subscores, with only HAMD factor 1 correlating to all 
PANSS subscores at discharge. This factor loaded items 
like ‘work interest’ and ‘retardation’, so that correlations 
with negative symptoms and general psychopathology 
are not surprising. The fact that we also found a signifi-
cant correlation between this factor and positive symp-
toms, which was even higher than the correlation at ad-
mission, might be explained by the well-known phe-
nomenon that due to the patients’ psychopathological 
improvement, both symptom domains move to a mini-
mum.
 When examining the factorial structure of the HAMD 
in schizophrenia patients, Goldman et al.  [9] correlated 
the HAMD total score only to negative symptoms, re-
porting no correlation at their initial assessment but find-
ing a significant correlation at the time point of follow-up. 
Similar to our own results, Addington et al.  [14] also iden-
tified a significant correlation between their first HAMD 
factor and negative symptoms, with factor 1 loading 
items like ‘depression’ or ‘somatic gastrointestinal’ as in 
the present analysis.
 Performing multiple regression analyses, we found all 
PANSS subscores to be significantly explained by the 
HAMD factors; however, the lowest score was for positive 
symptoms, followed by negative symptoms and general 
psychopathology. This result is in line with the only oth-
er trial that performed multiple regression analyses using 
HAMD factors and found the poor discriminant validity 
of the HAMD depression factors to be confirmed  [14] .
 Clinical Implications 
 The HAMD was found to be less stable and accounted 
for considerably less variance than the CDSS at both as-
sessment time points. Considering the correlation analy-
ses, more HAMD factors were significantly correlated to 
the PANSS subscores than CDSS factors. Moreover, the 
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correlation pattern of the CDSS factors and the PANSS 
subscores was very similar at admission and discharge 
compared to that of the HAMD factors and the patients’ 
psychopathology. Also, the results of the multiple regres-
sion analyses revealed a stronger association between the 
results of the HAMD factors and the PANSS subscores 
compared to the CDSS factors. This indicates that the 
HAMD factors explain more of the PANSS subscores 
than do the CDSS factors or, in other words, that there is 
‘more’ HAMD in the PANSS subscores compared to the 
CDSS. Both the CDSS and the HAMD mean scores as 
well as CDSS and HAMD factor 1 were significantly as-
sociated with the patients’ outcome, suggesting that pa-
tients with less depressive symptoms were significantly 
more likely to achieve early response, response and re-
mission. In terms of gender, we found female patients to 
suffer from more depressive symptoms when applying 
the CDSS.
 Taking these results together, the HAMD seems to be 
more confounded by symptoms of the PANSS positive 
and negative subscales than the CDSS. Future trials 
should further examine the association between the 
CDSS and patients’ psychopathology and should contin-
ue the discussion regarding the overlap between depres-
sive and negative symptoms  [36] . The stability and satis-
fying variance of the CDSS at both assessment time 
points suggest its advantage in the assessment of depres-
sive symptoms in schizophrenia patients.
 Strengths and Limitations 
 Advantages of the present analysis compared to previ-
ous research in this field are the large sample size and the 
fact that patients were treated under naturalistic condi-
tions with liberal inclusion and exclusion criteria. Includ-
ing patients suffering from suicidality as well as chroni-
cally ill and first-episode patients might increase the gen-
eralizability of our findings and exhibit higher external 
validity. Moreover, the study at hand is among the first to 
concurrently use a variety of different statistical methods 
(factor, correlation and regression analyses), thus provid-
ing broad information on the scales’ properties and use. 
Also, compared to other available studies, patients in this 
analysis were predominantly treated with atypical anti-
psychotics, which mirrors current treatment guidelines. 
A potential limitation, however, might be that at dis-
charge, most patients scored rather low on the CDSS and 
the HAMD, which has to be kept in mind when discuss-
ing the resolving factorial structure of the scales.
 Conclusion 
 Performing principal component analysis, the CDSS 
was found to hold a stable 3-factorial structure at admis-
sion and discharge whereas the item loadings of the 
HAMD were less stable, suggesting that the CDSS might 
be a more appropriate instrument to measure depressive 
symptoms in schizophrenia. Factors of both scales were 
significantly correlated to positive and negative symp-
toms as well as to the patients’ general psychopathology, 
with fewer and less significant correlations for the CDSS 
factors. The fact that both scales correlated with negative 
symptoms revives the discussion on whether or not the 
negative and depressive symptom domains in schizo-
phrenia are really independent psychopathological phe-
nomena.
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